Alzheimer’s Research UK Programme Award 2026

Captured cycle: This page is retained for historical guidance. Confirm whether the program has reopened before planning an application.

Alzheimer’s Research UK Programme Award 2026

The Alzheimer’s Research UK Programme Award supports established research leaders who want to bring several connected strands of dementia research together under one central theme. It is designed for a coordinated programme, rather than a single isolated project: the team is expected to combine complementary methods, disciplines and expertise to address a substantial research challenge. The current round is open, with Outline applications due by 28 October 2026. Alzheimer’s Research UK scheme page

At a glance

What the award is intended to support

The programme should have a clear dementia-research theme that gives its component workstreams a reason to sit together. The funder’s stated aim is to support ambitious, coordinated research that tackles major challenges in dementia, connects diverse methods and technologies, advances translation and patient benefit, and builds leadership and critical mass in the research community. Alzheimer’s Research UK Programme Award

That description points to a particular kind of fit. A proposal is more readily aligned when its component studies or approaches contribute to a shared question and when the team can explain how their combination advances the overall programme. A collection of projects under a broad dementia label may not, by itself, show integration. This is practical interpretation of the published aims, not a separate formal eligibility rule.

The scheme emphasizes team science: complementary approaches, disciplines and expertise are expected to work collaboratively. Applicants can use this to frame why the programme needs its proposed range of capabilities and how the workstreams connect. The brief does not prescribe a particular discipline mix, technology, disease subtype or research method, so applicants should not treat any one example as a required feature. Scheme description

Potential benefit for people affected by dementia is part of the assessment, alongside scientific excellence. The funder also identifies translation and patient benefit as aims. Applicants should make the intended path from research outputs to possible benefit understandable, while keeping the claim proportionate to what the programme can establish. No particular clinical outcome or guaranteed route to impact is specified in the available scheme information. Assessment and programme aims

Who should apply and eligibility

The Lead Applicant must be based at a UK university, hospital or research institution. Their contract must cover the proposed grant period. The scheme information describes the expected appointment as a fixed-term or tenure contract that covers the award; if the Lead Applicant does not hold a tenure appointment, the application must include a Joint Lead Applicant who does. Check both the contract end date and the proposed programme duration with the host institution before committing to a plan. Eligibility requirements

Co-applicants are not restricted to UK institutions. International researchers may participate as Co-Investigators or Collaborators, and small and medium enterprises may also participate in those roles. This gives an eligible UK lead room to assemble expertise across institutions or involve an SME where relevant to the research. It does not change the requirement for the Lead Applicant and, when applicable, the tenured Joint Lead Applicant. Eligibility requirements

How to apply

Applications go through Alzheimer’s Research UK’s Flexigrant grants system. A Flexigrant account is needed, and the Lead Applicant is responsible for submitting the application. The host institution must approve it through its Administrative Support contact before the deadline; the institution’s approval team should be registered in Flexigrant. Work back from the deadline to allow time for institutional review and approval, since completing the research narrative alone does not complete submission. Scheme application route

The process has two stages. First, submit an Outline application for Research Committee consideration. Only shortlisted applicants are invited to submit a Full application. Full applications include an interview, and the scheme says applicants receive committee feedback at each stage. An Outline submission is therefore the first selection point, not a guarantee of an invitation to the full stage. Programme Award process

The Flexigrant guidance says each invited participant must reach Complete status and provide an up-to-date CV, with Administrative Support excepted. Participants must finish their contributions before the system makes submission available. In practical terms, invite contributors early, confirm they can access the system, and monitor completion rather than assuming that a saved draft or an email exchange counts as a finished contribution. Application FAQs

At the Full application stage, the Research Committee’s review is supplemented by the Lived Experience Involvement group. Its review includes the Plain English Proposal, Patient and Public Involvement and Engagement plans, and Plain English Summary. These elements should communicate the programme and its relevance clearly to non-specialists and people affected by dementia. The source confirms that they are assessed at Full application; it does not establish from the information available here which named fields or attachments are required at Outline. Assessment process

The brief does not include the Outline form’s full questions or a complete required-attachments checklist. Use the live Flexigrant application and linked research guidance as the authority for the exact fields, formats, limits, approvals and attachments for this round. Do not substitute a checklist from another award scheme or assume that Full-stage materials are all due with the Outline.

How applications are assessed

The Research Committee assesses scientific excellence and potential impact for people affected by dementia. It also considers applicants’ skills, the team’s environment, fit with the scheme, and whether the requested resources are justified. These published areas suggest that a strong application needs to make the research case and the delivery case legible together: why the programme matters, why this team and environment can carry it out, and why the requested resources match the work. Assessment criteria

Timeline and deadlines

The current round is open. Outline applications opened in July 2026 and are due by 28 October 2026. Alzheimer’s Research UK expects to invite shortlisted applicants to submit a Full application in Spring 2027. The published timeline does not give a specific invitation date or the later Full application deadline, so applicants should consult Flexigrant and the funder’s updates rather than plan around an estimated date. Round timeline

Preparation advice and avoidable problems

The following are preparation suggestions, not additional published scheme rules. First, write a short programme logic before filling in the form: name the central research theme, show how each workstream contributes, and describe where the approaches or expertise complement one another. This helps distinguish an integrated programme from several adjacent projects and gives the resource request a coherent basis.

Next, check that the leadership and host arrangements work for the full proposed duration. Confirm the Lead Applicant’s contract dates and, if the Lead Applicant does not hold a tenure appointment, identify a qualifying Joint Lead Applicant early. International co-applicants and SME contributors are permitted in the stated Co-Investigator or Collaborator roles, but their roles and contributions still need to be clear in the application. These checks follow from the published eligibility terms; the precise institutional documentation to support them is not specified in the brief. Eligibility information

Coordinate the Flexigrant workflow before the final days. Make sure the host’s Administrative Support team is registered, identify who must contribute, and ask participants to complete their entries and update their CVs in good time. The FAQ specifically ties Complete status and participant contributions to the availability of submission. A practical internal schedule can include time for scientific review, plain-language review and institutional approval, but the funder’s page does not prescribe those internal milestones. Application FAQs

For Full-stage preparation, develop accessible explanations of the programme and its likely relevance, and plan meaningful Patient and Public Involvement and Engagement. These are sensible steps because those materials are assessed at Full application. Do not present them as a confirmed Outline-stage attachment requirement without checking the live form. Likewise, do not guess the application’s word limits, budget categories, or document formats: the complete Outline questions and attachment checklist remain unconfirmed in the public information provided for this article.

Frequently asked questions

Is the maximum award £1.5 million for five years?

The award offers up to £1.5 million over a maximum of five years. Both are stated maximums. The application should request the amount and duration needed for the proposed programme and justify its resources; the published information does not say that every award reaches either ceiling. Scheme details

Can an international researcher lead the application?

The Lead Applicant must be based at a UK university, hospital or research institution. International co-applicants are permitted as Co-Investigators or Collaborators, but the supplied eligibility information does not extend the Lead Applicant role to an overseas host. Eligibility

Does every applicant submit a Full application?

No. The process begins with an Outline application. Only shortlisted applicants are invited to submit a Full application, which includes an interview. The scheme reports feedback at each stage. Application stages

What must be attached to the Outline?

The full Outline questions and complete attachment checklist are not stated in the information available here. Check the current Programme Award application in Flexigrant and the linked researcher guidance for the exact requirements. The FAQ separately says invited participants need Complete status and an up-to-date CV, except Administrative Support; that system guidance should not be mistaken for a complete Outline attachment list. Scheme page · Application FAQs

When will Full applications be due?

The confirmed timeline says invitations are expected in Spring 2027. It does not provide a specific invitation date or Full application deadline in the brief. Check the invitation and current Flexigrant instructions for those dates. Round timeline

Official sources

• Alzheimer’s Research UK Programme Award — scheme aims, award limits, eligibility, assessment and round timeline.
• Alzheimer’s Research UK grant application FAQs — Flexigrant participant completion and CV guidance.

The current Flexigrant application and its linked research guidance should be used to verify the complete Outline form, attachment checklist and any instructions that are not specified on the public scheme page. Those details remain unconfirmed in the information used here.